ct-2584
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 1998 (NCT00004026)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCCCCCCCNCC(O)CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O- Mol. weight
- 533.8 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297274 ↗
Also known as
- 1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine
- ct2584
- ct 2584
- ct-2584
- ct-2584
- ct-2584
- ct-2584
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004026 | Phase 2 | Dec 1, 1998 | CTI BioPharma |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CTI BioPharma | For profit | 1 | 1 | 1 | 1998 |
1 organizations
Page 1 / 1